IL2RA and type 1 diabetes mellitus: In the NOD mouse model of T1D, as well as in T1D patients, deficiencies in the Treg TCR repertoire (7), the IL-2/IL-2Rα pathway (8–11) and suppressor mechanisms such as CTLA-4 (12) may all contribute to reduced Treg functionality.